Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to evaluate associations between in utero vitamin D status and childhood cardiometabolic risk factors.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

All participants were advised to fast overnight for ≥ 8 h on the day before the evaluation of arterial stiffness.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Associations of umbilical cord vitamin D levels with childhood cardiometabolic risks: a longitudinal mother-child study

Study design awaiting verification · Frontiers in Nutrition · 2026

Original publication title

Associations of umbilical cord vitamin D levels with childhood cardiometabolic risks: a longitudinal mother: child study

Di Mao; Hanbin Wu; Lai-Yuk Yuen; Chung-Shun Ho; Claudia Ha-Ting Tam; Michael Ho-Ming Chan; William L. Lowe Jr.; Ronald Ching-Wan Ma; Chi-Chiu Wang; Wing-Hung Tam

Copyright © 2026 Mao, Wu, Yuen, Ho, Tam, Chan, Lowe, Ma, Wang and Tam.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

A low umbilical cord serum 25(OH)D level at birth, but not maternal serum 25(OH)D in 24 to 32 weeks of gestation, was associated with higher childhood diastolic BP, arterial stiffness, and fasting PG levels. Although maternal total 25(OH)D levels between 24 and 32 gestational weeks were not associated with childhood cardiometabolic risks, our findings indicated that neonatal vitamin D status at birth may be relevant to childhood vascular and glucose metabolic health. Given the observational study design and modest effect size, these findings should be interpreted cautiously and warrant further investigations.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D inadequacy is globally prevalent among pregnant women, but its impact on offspring cardiometabolic risks remains inconclusive. This study aimed to evaluate associations between in utero vitamin D status and childhood cardiometabolic risk factors.

Source: Background

Abstract: What methods does the paper describe?

In the original Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study, all pregnant women booked for antenatal care, except teenage pregnancy, plan to delivery at another hospital, uncertain last menstrual period and no ultrasonographic estimated gestational age, inability to complete the oral glucose tolerance test (OGTT), multiple pregnancy, conception by assisted reproduction, glucose testing before recruitment, or diagnosis of diabetes during or before the current pregnancy and required medication. Archived maternal serum samples from 24 to 32 gestational weeks and umbilical cord serum samples at birth in the original HAPO Study at the Hong Kong Centre were assayed for total 25-hydroxyvitamin D [25(OH)D] levels by using liquid chromatography-tandem mass spectroscopy.

Children’s clinical and biochemistry parameters were collected at the HAPO Follow-Up Study at around age 7, including anthropometry, blood pressure (BP), carotid-femoral pulse wave velocity (cfPWV), fasting lipid profile, plasma glucose (PG), and insulin levels at OGTT. Linear regression analyses were used to evaluate the associations of in-utero 25(OH)D levels with children’s cardiometabolic risk factors.

Source: Methods

Abstract: Findings

There was no association between maternal serum total 25(OH)D level in 24 to 32 weeks of gestation and childhood cardiometabolic risk factors. In contrast, umbilical cord serum total 25(OH)D level at birth was negatively associated with offspring diastolic BP, cfPWV, and fasting PG at around age 7, whereas no significant results were observed in other cardiometabolic risk factors. Every 1-SD (18.0 nmol/L) increase in the umbilical cord serum total 25(OH)D level was independently associated with a reduction in diastolic BP, cfPWV, and fasting PG by 0.73 mmHg (95% CI [−1.44, −0.02], p = 0.044), 0.08 m/s ([−0.14, −0.03], p = 0.004), and 0.04 mmol/L ([−0.07, −0.01], p = 0.017), respectively.

However, only associations with cfPWV and fasting PG remained significant after correction for multiple testing.

Source: Findings

Abstract: Interpretation

A low umbilical cord serum 25(OH)D level at birth, but not maternal serum 25(OH)D in 24 to 32 weeks of gestation, was associated with higher childhood diastolic BP, arterial stiffness, and fasting PG levels. Although maternal total 25(OH)D levels between 24 and 32 gestational weeks were not associated with childhood cardiometabolic risks, our findings indicated that neonatal vitamin D status at birth may be relevant to childhood vascular and glucose metabolic health. Given the observational study design and modest effect size, these findings should be interpreted cautiously and warrant further investigations.

Source: Interpretation
Authors’ abstract

Background

Vitamin D inadequacy is globally prevalent among pregnant women, but its impact on offspring cardiometabolic risks remains inconclusive. This study aimed to evaluate associations between in utero vitamin D status and childhood cardiometabolic risk factors.

Methods

In the original Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study, all pregnant women booked for antenatal care, except teenage pregnancy, plan to delivery at another hospital, uncertain last menstrual period and no ultrasonographic estimated gestational age, inability to complete the oral glucose tolerance test (OGTT), multiple pregnancy, conception by assisted reproduction, glucose testing before recruitment, or diagnosis of diabetes during or before the current pregnancy and required medication. Archived maternal serum samples from 24 to 32 gestational weeks and umbilical cord serum samples at birth in the original HAPO Study at the Hong Kong Centre were assayed for total 25-hydroxyvitamin D [25(OH)D] levels by using liquid chromatography-tandem mass spectroscopy.

Children’s clinical and biochemistry parameters were collected at the HAPO Follow-Up Study at around age 7, including anthropometry, blood pressure (BP), carotid-femoral pulse wave velocity (cfPWV), fasting lipid profile, plasma glucose (PG), and insulin levels at OGTT. Linear regression analyses were used to evaluate the associations of in-utero 25(OH)D levels with children’s cardiometabolic risk factors.

Findings

There was no association between maternal serum total 25(OH)D level in 24 to 32 weeks of gestation and childhood cardiometabolic risk factors. In contrast, umbilical cord serum total 25(OH)D level at birth was negatively associated with offspring diastolic BP, cfPWV, and fasting PG at around age 7, whereas no significant results were observed in other cardiometabolic risk factors. Every 1-SD (18.0 nmol/L) increase in the umbilical cord serum total 25(OH)D level was independently associated with a reduction in diastolic BP, cfPWV, and fasting PG by 0.73 mmHg (95% CI [−1.44, −0.02], p = 0.044), 0.08 m/s ([−0.14, −0.03], p = 0.004), and 0.04 mmol/L ([−0.07, −0.01], p = 0.017), respectively.

However, only associations with cfPWV and fasting PG remained significant after correction for multiple testing.

Interpretation

A low umbilical cord serum 25(OH)D level at birth, but not maternal serum 25(OH)D in 24 to 32 weeks of gestation, was associated with higher childhood diastolic BP, arterial stiffness, and fasting PG levels. Although maternal total 25(OH)D levels between 24 and 32 gestational weeks were not associated with childhood cardiometabolic risks, our findings indicated that neonatal vitamin D status at birth may be relevant to childhood vascular and glucose metabolic health. Given the observational study design and modest effect size, these findings should be interpreted cautiously and warrant further investigations.

Publication and source details

Original title: Associations of umbilical cord vitamin D levels with childhood cardiometabolic risks: a longitudinal mother: child study

Di Mao; Hanbin Wu; Lai-Yuk Yuen; Chung-Shun Ho; Claudia Ha-Ting Tam; Michael Ho-Ming Chan; William L. Lowe Jr.; Ronald Ching-Wan Ma; Chi-Chiu Wang; Wing-Hung Tam

Frontiers in Nutrition · 2026

* Correspondence: Wing-Hung Tam, tamwh@cuhk.edu.hk; Chi-Chiu Wang, ccwang@cuhk.edu.hk
†

These authors have contributed equally to this work

Copyright © 2026 Mao, Wu, Yuen, Ho, Tam, Chan, Lowe, Ma, Wang and Tam.2026Mao, Wu, Yuen, Ho, Tam, Chan, Lowe, Ma, Wang and Tamhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. The HAPO study was funded by the National Institute of Child Health and Human Development (grant R01-HD34242), and the National Institute of Diabetes and Digestive and Kidney Diseases (grant R01-HD34243). The HAPO follow-up study in the Hong Kong Centre was supported by funding from the Research Grants Council of the Hong Kong SAR, China (grants CUHK 473408 and, in part, CUHK 471713). The work on vitamin D analysis was supported by funding from the Research Grants Council of the Hong Kong SAR, China (#CUHK 14118316 and 14102719). The funding sources do not have any role in the design, interpretation of the study, or the decision to publish the results.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T16:26:42.381267+00:00

DOI: 10.3389/fnut.2026.1777909 · PMC13111193